A reproducibility review does not begin at the review meeting. It begins at the bench, when the first vial is logged and the first diluent volume is recorded. Reconstitution is a short, routine step, which is exactly why it is often under-documented. A colleague who inherits the work may know the product name but not the batch reference, the diluent lot, the mixing method, the concentration used for the in-vitro assay, or the storage conditions applied afterwards. The result is a record that describes an outcome without describing the work. For a review to be meaningful, the reconstitution step must be written so that another researcher can repeat it, compare it, and challenge it. All materials discussed here are for controlled laboratory and analytical research only; they are not for human or veterinary use.
Define the Reconstitution Record Before the First Drop
Start the record before the vial is opened. A useful header captures the experiment identifier, the research question, the researcher’s name, the date and time of preparation, the review date, and the record version. These fields seem administrative until a reviewer asks which version was used, or which preparation fed a particular assay. Version control is not bureaucracy; it is the difference between a repeatable method and a reconstruction after the fact.
The material traceability block should be precise. Record the product name, catalogue code, vial label reference, and the batch-specific CoA. Research Sciences uses label references that combine a SKU code and an expiry date, such as BPC10-03/27, and the shop advises researchers to quote that reference when contacting them about documentation. If the product is restocked, the FAQ notes that the same Internal Test Reference (ITR) may appear on earlier stock; an ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. A reviewer should see this distinction in the record, not discover it later. Vial cap colour and other packaging details may vary and should not be recorded as evidence of identity or quality.
Record the diluent by name, supplier, lot, and volume, along with the labware and pipettes used. If a reconstitution calculator is used, note its inputs and outputs, the concentration calculated for the in-vitro assay, and the fact that it is intended for laboratory research only. It must not be used for human or veterinary dosing. Record the storage history of the lyophilised vial before preparation: Research Sciences’ handling guidance describes storage at –20°C or below, sealed with desiccant and protected from moisture, heat, and light. Note the time the vial was removed from storage and allowed to reach ambient temperature before reconstitution in the research setting. This preamble turns a vague “vial reconstituted” note into a traceable starting condition.
Write the Step So Another Researcher Can Follow It Without Guesswork
The procedure should be written in the order it is performed and with enough detail that a competent colleague can reproduce it without asking informal questions. State the environment and equipment: clean bench area, gloves, calibrated pipette, suitable tube or vial, and the diluent volume. Record whether the whole vial was reconstituted or only the amount required for the experiment. If only part was used, say how the remainder was handled. Record the target concentration for the in-vitro assay and the calculation that produced it. Avoid shorthand such as “standard reconstitution” unless “standard” is defined in a controlled protocol that the record references.
Describe the physical steps in plain language. For example: allow the peptide vial and solvent to reach ambient temperature; work in a clean environment; add the recorded volume of diluent; mix using the laboratory’s validated technique; observe dissolution. Do not invent a mixing method or stability claim that is not supported by the batch CoA or the approved laboratory procedure. If gentle swirling was used, write “gentle swirling”; if the protocol requires a different method, record that instead. Note any foaming, incomplete dissolution, visible particles, colour change, or delay. Deviations are not failures; they are data. A reviewer needs to know whether the step proceeded as written or whether the record has been tidied after the event.
For a current list of research-use-only peptides, preparation tools, and laboratory accessories, the catalogue can be reviewed through the Buy peptides listing, but the individual product page and the batch CoA remain the controlling documents for that material. Research Sciences describes batch-level analytical verification and CoAs linked to supported products; the exact purity, identity, and storage details should be reconfirmed on the specific CoA and the live site rather than assumed from a category page. If the CoA or product page gives a post-reconstitution storage temperature, record it exactly as written. General shop guidance describes reconstituted peptides as less stable and recommends 2–8°C for short-term laboratory use; where a product-specific instruction differs, the product documentation takes precedence. Repeat the research-use-only status in the record: not for human or veterinary use, not for consumption or clinical application.
Verify, Review, and Hand Over the Record Before Reproducibility Review
A reconstitution record is ready for review when another researcher can read it without the author present. Ask a colleague to perform a dry run: can they identify the exact product, batch, CoA, diluent, volume, calculation, mixing method, observations, and storage conditions? Can they tell which steps were planned and which were changed? If the answer is no, the record is not yet repeatable. The reviewer should also check that the CoA is attached or linked by a stable internal reference, that the label reference is transcribed correctly, and that any ITR is described as a testing reference rather than a production-lot guarantee.
Include a review block with names, dates, and version numbers. Record where the record is stored, how it is named, and who has permission to amend it. If the preparation is repeated, create a new record rather than overwriting the old one; the comparison between runs is often the most useful evidence in a reproducibility review. Note the equipment calibration status and any environmental conditions that the laboratory normally records. If the work falls under COSHH or local laboratory safety standards, the record should point to the relevant risk assessment and disposal route without attempting to replace them. The purchaser and researcher remain responsible for lawful use, safe handling, storage, and disposal.
The handover check
Before handover, reconfirm the batch documentation. Research Sciences’ current published wording should be checked on the live site and, where relevant, on the batch CoA; do not carry forward a purity figure, storage instruction, or delivery statement from an older note without checking it against the current document. If the CoA mentions Janoshik Analytical Reports, record only what the document actually states. Package cap colour, ITR reuse, and catalogue listing text are not substitutes for batch-specific verification. A strong handover ends with a clear statement of what was done, what was observed, what was stored, and what a colleague must check before repeating the work. The record is then not a narrative of activity but a laboratory instrument in its own right, ready for scrutiny and repeatability.
Hailing from Valparaíso, Chile and currently living in Vancouver, Teo is a former marine-biologist-turned-freelance storyteller. He’s penned think-pieces on deep-sea drones, quick-fire guides to UX design, and poetic musings on street food culture. When not at the keyboard, he’s scuba-diving or perfecting his sourdough. Teo believes every topic has a hidden tide waiting to be charted.